Harvard Bioscience Inc Market Cap ($36.56 Million)
Market Cap & Net Worth: Harvard Bioscience Inc (HBIO)
Harvard Bioscience Inc market cap. Harvard Bioscience Inc (NASDAQ:HBIO) has a market capitalization of $36.56 Million ($36.56 Million) as of November 3, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #22866 globally and #5026 in its home market, demonstrating a 4.50% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Harvard Bioscience Inc's stock price $8.60 by its total outstanding shares 4552305 (4.55 Million). Also see how efficiently does Harvard Bioscience Inc generate cash for how efficiently the company converts equity into cash flow.
Harvard Bioscience Inc Market Cap History (2015–2026)
Harvard Bioscience Inc market cap history from 2015 to 2026. Data shows growth from $15.80 Million to $39.15 Million (7.57% CAGR). Check HBIO stock price for real-time trading data and today's change.
Index Memberships
Harvard Bioscience Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.60 Trillion | 0.00% | #641 of 976 |
|
NASDAQ Composite
IXIC
|
$39.84 Trillion | 0.00% | #2143 of 3165 |
Weight: Harvard Bioscience Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Harvard Bioscience Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Harvard Bioscience Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore HBIO net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
Harvard Bioscience Inc's market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $13.88 Million | $104.52 Million | -$4.31 Million | 0.13x | N/A |
| 2017 | $15.02 Million | $101.88 Million | -$865.00K | 0.15x | N/A |
| 2018 | $14.48 Million | $120.77 Million | -$3.46 Million | 0.12x | N/A |
| 2019 | $13.88 Million | $116.18 Million | -$4.69 Million | 0.12x | N/A |
| 2020 | $19.53 Million | $102.10 Million | -$7.81 Million | 0.19x | N/A |
| 2021 | $32.09 Million | $118.90 Million | -$288.00K | 0.27x | N/A |
| 2022 | $12.61 Million | $113.33 Million | -$9.52 Million | 0.11x | N/A |
| 2023 | $24.35 Million | $112.25 Million | -$3.42 Million | 0.22x | N/A |
| 2024 | $9.61 Million | $94.14 Million | -$12.40 Million | 0.10x | N/A |
| 2025 | $3.04 Million | $86.55 Million | -$56.70 Million | 0.04x | N/A |
Competitor Companies of HBIO by Market Capitalization
Companies near Harvard Bioscience Inc in the global market cap rankings as of November 3, 2026. Also see Harvard Bioscience Inc assets under control for a full breakdown of the balance sheet.
Key companies related to Harvard Bioscience Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #175 globally with a market cap of $132.26 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #249 globally with a market cap of $101.18 Billion USD ( €86.54 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #419 globally with a market cap of $67.43 Billion USD ( €57.68 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #537 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #175 | Intuitive Surgical Inc | NASDAQ:ISRG | $132.26 Billion | $436.87 |
| #249 | EssilorLuxottica S. A. | PA:EL | $101.18 Billion | €186.90 |
| #419 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $67.43 Billion | €93.00 |
| #537 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Market Capitalization of Harvard Bioscience Inc (2015–2026)
Market capitalization of Harvard Bioscience Inc from 2015 to today. Between 2015 and today, Harvard Bioscience Inc's market cap moved from $15.80 Million to $ 39.15 Million, with a yearly change of 7.57%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $39.15 Million | +1185.89% |
| 2025 | $3.04 Million | -68.30% |
| 2024 | $9.61 Million | -60.56% |
| 2023 | $24.35 Million | +93.14% |
| 2022 | $12.61 Million | -60.71% |
| 2021 | $32.09 Million | +64.34% |
| 2020 | $19.53 Million | +40.66% |
| 2019 | $13.88 Million | -4.09% |
| 2018 | $14.48 Million | -3.64% |
| 2017 | $15.02 Million | +8.20% |
| 2016 | $13.88 Million | -12.10% |
| 2015 | $15.80 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Harvard Bioscience Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.56 Million USD |
| MoneyControl | $36.56 Million USD |
| MarketWatch | $36.56 Million USD |
| marketcap.company | $36.56 Million USD |
| Reuters | $36.56 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Harvard Bioscience Inc
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrop… Read more